T1R3 and gustducin in gut sense sugars to regulate expression of Na + -glucose cotransporter 1
Robert F. Margolskee, Jane Dyer, Zaza Kokrashvili, Kieron S. H. Salmon, Erwin Ilegems, Kristian Daly, Émeline L. Maillet, Yuzo Ninomiya, Bedrich J. Mosinger, Soraya P. Shirazi‐Beechey
Proceedings of the National Academy of Sciences · 2007 · 904 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Margolskee, R. F., Dyer, J., Kokrashvili, Z., Salmon, K. S. H., Ilegems, E., Daly, K., Maillet, É. L., Ninomiya, Y., Mosinger, B. J., & Shirazi‐Beechey, S. P. (2007). T1R3 and gustducin in gut sense sugars to regulate expression of na + -glucose cotransporter 1. Proceedings of the National Academy of Sciences, 104(38), 15075–15080. https://doi.org/10.1073/pnas.0706678104
In text: (Margolskee et al., 2007)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
Dietary sugars are transported from the intestinal lumen into absorptive enterocytes by the sodium-dependent glucose transporter isoform 1 (SGLT1). Regulation of this protein is important for the provision of glucose to the body and avoidance of intestinal malabsorption. Although expression of SGLT1 is regulated by luminal monosaccharides, the luminal glucose sensor mediating this process was unknown. Here, we show that the sweet taste receptor subunit T1R3 and the taste G protein gustducin, expressed in enteroendocrine cells, underlie intestinal sugar sensing and regulation of SGLT1 mRNA and protein. Dietary sugar and artificial sweeteners increased SGLT1 mRNA and protein expression, and glucose absorptive capacity in wild-type mice, but not in knockout mice lacking T1R3 or alpha-gustducin. Artificial sweeteners, acting on sweet taste receptors expressed on enteroendocrine GLUTag cells, stimulated secretion of gut hormones implicated in SGLT1 up-regulation. Gut-expressed taste signaling elements involved in regulating SGLT1 expression could provide novel therapeutic targets for modulating the gut's capacity to absorb sugars, with implications for the prevention and/or treatment of malabsorption syndromes and diet-related disorders including diabetes and obesity.
Related papers
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus1993
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin2002
- International Diabetes Federation 20172018
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance2001
Metadata from OpenAlex (CC0). Citations are generated from the published record.